• Products
  • Suppliers
  • Sourcing Requests
Post Sourcing Request Exhibition
Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising
New Products
3-Bromo-4-fluorobenzaldehyde
5-Methyl-1,3,4-oxadiazol2(3H)-one
4-Amino-6-methyl-3 oxo2,3, 4,5-tetrahydro 1.2.4-triazine hydrochloride
4-Acetylamino-6-methyl -3-oxo-2,3,4,5-tetrahydro-1,2,4-triazine
3-Pyridinecarboxaldehyde
Ethyl 3 Fluorobenzoate

Morocco’s Sothema to produce China’s Sinopharm vaccine

firstwordpharmaJuly 06, 2021

Tag: Sothema , COVID-19 , Vaccine

Moroccan pharmaceutical firm Sothema will soon start producing 5 million doses of Sinopharm's COVID-19 vaccine in the North African country, as reported in Yahoo!News.

Morocco’s Sothema to produce China’s Sinopharm vaccine

The Moroccan government also signed a deal with Sweden’s Recipharm to set up a plant in Morocco to produce other key vaccines.

The news source said Morocco, which rolled out a COVID-19 vaccination campaign in January, has inoculated more people against the virus than other African countries.

It had administered 19.2 million doses of the Sinopharm and AstraZeneca vaccines as of July 5.


Previous:Psilera Raises $2.5 Million with Oversubscribed Series Seed from Leading Institutional Investors to Accelerate Clinical Pipeline Focused on DMT

Next:Valneva to Host Symposium on COVID-19 and Chikungunya Vaccine Candidates at 31st European Congress of Clinical Microbiology & Infectious Diseases

Related News

Sartorius Stedim Biotech Opens New Center for Bioprocess Innovation in Marlborough, USA

PharmaSourcesNovember 22, 2024

Sartorius Stedim Biotech, a leading partner of the biopharmaceutical industry, today opened its new Center for Bioprocess Innovation in Marlborough, Massachusetts.

BioPharmaSpec Announces Three New Facilities in Freiburg, Bergamo and Vilnius

Biotech NewswireNovember 20, 2024

Rona Therapeutics Presented Positive Phase 1 Results of RN0191, a Novel siRNA Therapy Targeting PCSK9, at the 2024 American Heart Association (AHA) Scientific Sessions

PR NEWSWIRENovember 20, 2024

Morocco’s Sothema to produce China’s Sinopharm vaccine | Pharmasources.com

AI in Pharmacovigilance: Predicting & Preventing Drug Risks

Nurah EkhlaqueNovember 19, 2024

Discover how AI in pharmacovigilance improves drug safety by predicting risks, identifying harmful interactions, and enhancing patient outcomes.

You may like
More>>

SARS-CoV-2 (COVID-19) IgM/IgG ANTIBODY FAST DETECTION KIT (COLLOIDAL GOLD)

SARS-CoV-2 (COVID-19) IgM/IgG ANTIBODY FAST DETECTION KIT (COLLOIDAL GOLD)
Quadrivalent Influenza Vaccine

Quadrivalent Influenza Vaccine
OPV(Poliomyelitis(Live)Vaccine(Monkey Kidney Cell).Oral

OPV(Poliomyelitis(Live)Vaccine(Monkey Kidney Cell).Oral
Poliomyelitis (Live) Vaccine Type I Type III (Human Diploid Cell), Oral

Poliomyelitis (Live) Vaccine Type I Type III (Human Diploid Cell), Oral
Rabies Vaccine(Vero Cell)for Human use

Rabies Vaccine(Vero Cell)for Human use
Enterovirus Type 71 Vaccine, Inactivated (Human Diploid Cell)

Enterovirus Type 71 Vaccine, Inactivated (Human Diploid Cell)
Hualan good immunogenicity performance Influenza Vaccine

Hualan good immunogenicity performance Influenza Vaccine
Cheap Influenza Vaccine

Cheap Influenza Vaccine
Influenza Vaccine(Split Virion),Inactivated

Influenza Vaccine(Split Virion),Inactivated
Flu Vaccine by Hualan Bio

Flu Vaccine by Hualan Bio

Contact Us

PharmaSources@imsinoexpo.com

Tel: (+86) 400 610 1188

WhatsApp/Telegram/Wechat: +86 13621645194

About Us
About PharmaSources
Terms of Service
Privacy Policy
Intellectual Property
Media Partners
Buy
Search Products
Post Sourcing Requests
Search Suppliers
CAS Search
Sell
Member Application
Advertising
Post Products
EZSourcing
Events
CPHI China
PMEC China
Conferences
Search Events
Help
FAQ
Contact Us
Feedback
PharmaSources Customer Service